A F Wilson, J J McPhillips. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acetylcholine/antagonists & inhibitorsAdrenergic alpha-Antagonists/therapeutic useAdrenergic beta-Agonists/therapeutic useAerosolsAsthma/drug therapyAsthma/etiologyBronchodilator Agents/administration & dosageChronic DiseaseDrug ToleranceEphedrine/therapeutic useGlucocorticoids/therapeutic useHistamine H1 Antagonists/therapeutic useHumansIsoproterenol/therapeutic useMast Cells/drug effectsOxygen/bloodPhosphodiesterase Inhibitors/therapeutic usePhysical ExertionProstaglandins/therapeutic useSRS-A/antagonists & inhibitorsSympathomimetics/therapeutic use
Substances: See more » Adrenergic alpha-AntagonistsAdrenergic beta-AgonistsAerosolsBronchodilator AgentsGlucocorticoidsHistamine H1 AntagonistsPhosphodiesterase InhibitorsProstaglandinsSRS-ASympathomimeticsEphedrineIsoproterenolAcetylcholineOxygen
Year: 1978 PMID: 25612 DOI: 10.1146/annurev.pa.18.040178.002545
Source DB: PubMed Journal: Annu Rev Pharmacol Toxicol ISSN: 0362-1642 Impact factor: 13.820